IP Library › Granted Patent US 9,011,523
Granted Patent B2
US 9,011,523 · App. 13/527,463 · Granted Apr 21, 2015

Prosthetic leaflet assembly for repairing a defective cardiac valve and methods of using the same

Inventor: Jacques Seguin (Gstaad, CH)
A61F2/246A61F2/2418A61F2/2454
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,011,523
App. No.
13/527,463
Granted
Apr 21, 2015
Kind
B2
Abstract

Methods and apparatus are provided for repairing or replacing a defective cardiac valve including a prosthetic leaflet assembly having an expandable frame with one or more anchors configured to engage a predetermined region of the defective cardiac valve in an expanded deployed state, and at least one prosthetic leaflet coupled to the expandable frame. The prosthetic leaflet assembly is configured such that the prosthetic leaflet is suspended within a flow path of the defective cardiac valve and coapts with, and improves functioning of, one or more native leaflets of the defective cardiac valve.

Claims (24)

1. A prosthetic leaflet assembly for repairing a defective cardiac valve having two or more native leaflets defining a flow path through a central opening of the defective cardiac valve, the prosthetic leaflet assembly comprising:

an expandable frame configured to transition from a contracted delivery state to an expanded deployed state, the expandable frame having one or more anchors configured to engage a predetermined region of the defective cardiac valve in the expanded deployed state; and

one or more prosthetic leaflets coupled to the expandable frame, the one or more prosthetic leaflets configured to be suspended within the flow path and to occupy a portion of the central opening such that the one or more prosthetic leaflets coapt with, and improve functioning of, the two or more native leaflets.

2. The prosthetic leaflet assembly of claim 1 , wherein the expandable frame further comprises one or more stabilization members configured to be disposed upstream of the defective cardiac valve to prevent the two or more native leaflets from prolapsing and to prevent migration of the prosthetic leaflet assembly.

3. The prosthetic leaflet assembly of claim 1 , wherein the expandable frame further comprises one or more biasing members configured to urge the one or more anchors into engagement with the predetermined region.

4. The prosthetic leaflet assembly of claim 1 , wherein the one or more anchors comprise first and second anchors, and wherein the one or more prosthetic leaflets are disposed between the first and second anchors.

5. The prosthetic leaflet assembly of claim 1 , wherein the predetermined region comprises commissural areas of the defective cardiac valve.

6. The prosthetic leaflet assembly of claim 1 , wherein the expandable frame and the one or more prosthetic leaflets are configured to transition between a delivery state enabling transcatheter delivery and an expanded, deployed state.

7. The prosthetic leaflet assembly of claim 1 , wherein the prosthetic leaflet assembly is configured to repair one of a mitral valve, a tricuspid valve, an aortic valve, or a pulmonary valve.

8. The prosthetic leaflet assembly of claim 1 , wherein the expandable frame is self-expanding.

9. The prosthetic leaflet assembly of claim 8 , wherein the expandable frame comprises a nickel-titanium alloy.

10. The prosthetic leaflet assembly of claim 1 , wherein the one or more prosthetic leaflets comprise animal tissue.

11. The prosthetic leaflet assembly of claim 10 , wherein the animal tissue comprises porcine, equine, or bovine pericardial tissue.

12. The prosthetic leaflet assembly of claim 1 , wherein the one or more prosthetic leaflets comprise a synthetic fabric.

13. The prosthetic leaflet assembly of claim 1 , wherein the prosthetic leaflet assembly is configured to be delivered transvascularly or transapically using a minimally invasive approach.

14. The prosthetic leaflet assembly of claim 1 , wherein the expandable frame is configured to accommodate deployment of a replacement valve, such that the expandable frame serves as an anchor for the replacement valve.

15. The prosthetic leaflet assembly of claim 14 , wherein the replacement valve is configured to be implanted seconds, days, months, or years after the prosthetic leaflet assembly is deployed.

16. The prosthetic leaflet assembly of claim 1 , wherein the portion that the one or more prosthetic leaflets occupy is between 5 to 35 percent of the central opening of the defective cardiac valve.

17. A method of repairing a defective cardiac valve having two or more native leaflets defining a flow path through a central opening of the defective cardiac valve, the method comprising:

providing a prosthetic leaflet assembly having one or more prosthetic leaflets mounted on an expandable frame, the expandable frame having one or more anchors;

implanting the prosthetic leaflet assembly in a heart having the defective cardiac valve by engaging the one or more anchors to a predetermined region of the defective cardiac valve, such that the one or more prosthetic leaflets are suspended within the flow path and occupy a portion of the central opening such that the one or more prosthetic leaflets coapt with, and improve functioning of, the two or more native leaflets.

18. The method of claim 17 , wherein engaging the predetermined region further comprises transitioning the prosthetic leaflet assembly between a delivery state and an expanded, deployed state.

19. The method of claim 17 , wherein the expandable frame is self-expanding, and wherein engaging the predetermined region further comprises releasing the self-expanding expandable frame.

20. The method of claim 17 , further comprising preventing the two or more native leaflets from prolapsing during systole using one or more stabilization members of the expandable frame disposed upstream of the defective cardiac valve.

Continuity (2)
Provisional Application 61498991 · Jun 20, 2011
Related Publication 20120323313A1 · Dec 20, 2012